Endogenex - Crunchbase Company Profile & Funding

Q: Where is Endogenex's headquarters?

Endogenex is located in Plymouth, Minnesota, United States.

Q: Who invested in Endogenex?

Endogenex has 9 investors including Arboretum Ventures And Intuitive Ventures.

Q: When was the last funding round for Endogenex?

Endogenex closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Endogenex raised to date?

Endogenex has raised obfuscated.

Overview

Endogenex

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Endogenex

CB Rank

15990

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

Founded

obfuscation

Private

Series C

Plymouth, Minnesota, United States

11-50

www.endogenex.com

Health Care

Medical Device

Therapeutics

Funding Rounds

Series C

OBF

obfuscation

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

John Deedrick: Co-Founder and Executive Chairman
Stacey Scoggin Pugh: CEO

Details

Legal Name

Endogenex Inc.

Also Known As

DyaMX

Operating Status

Active

Company Type

For Profit

Founders

John Deedrick, Michael Brenzel, Paul Hindrichs

About the Company

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D.

Phone Number

+1 763 251-6820

Contact Email

info@Endogenex.com

Predictions & Insights

Growth Insight

See this Growth Insight

Endogenex is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

ReCET System

An investigational endoscopic system applying pulsed electric fields to the duodenum to restore metabolic signaling and improve blood glucose control in type 2 diabetes patients.

ReCET Procedure

An outpatient endoscopic procedure using the ReCET System to apply pulsed electric fields to the duodenum, triggering cellular regeneration to improve metabolic function in type 2 diabetes patients.

Research & Development

Endogenex is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C
obfuscated obfuscation	Series C - Endogenex	1	obfuscated obfuscation	Arboretum Ventures	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Arboretum Ventures	Yes	Series C - Endogenex	Tom Shehab
Arboretum Ventures	Yes	Series C - Endogenex	Tom Shehab
Arboretum Ventures	Yes	Series C - Endogenex	Tom Shehab
Arboretum Ventures	Yes	Series C - Endogenex	Tom Shehab
Arboretum Ventures	Yes	Series C - Endogenex	Tom Shehab